ArticlePLoS computational biology2026
GHF-ACL: A novel contrastive learning framework with multi-order graph structures for herb-disease association prediction.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting Herb-Disease Associations (HDA) is pivotal for modernizing Traditional Chinese Medicine (TCM); however, this is impeded by data heterogeneity and the complex, multi-component mechanisms of herbal medicines. Existing drug-disease prediction models often struggle to capture high-order structural patterns and resolve semantic inconsistencies intrinsic to herbs. To overcome these limitations, we present HData, a standardized benchmark dataset that integrates herbal medicinal properties, chemical compositions, and disease associations. We further propose GHF-ACL, a novel multi-order graph contrastive learning framework designed for HDA prediction. Specifically, GHF-ACL explicitly models low-order functional similarities via a herb-disease similarity graph while capturing high-order component interactions through a herb-chemical hypergraph. Furthermore, an adaptive gating-guided structural interaction module aligns heterogeneous graph representations into a unified latent space, and hierarchical contrastive learning enforces consistency across structural views. Extensive experiments on five datasets demonstrate that GHF-ACL achieves superior or competitive performance over six state-of-the-art models across most metrics, with significant improvements over the best-performing baseline model in AUPR (+4.8% on LRSSL, + 3.81% on Cdata), F1 score, and Recall. These results underscore the model's superior capability in detecting true positive associations within imbalanced biomedical data. By synergizing multi-view graph modeling, semantic fusion, and contrastive regularization, this work establishes a unified framework for HDA prediction, offering valuable insights for computational TCM and data-driven drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.